Back
Speaker illustration

Miss Amelie Paasche

Heidelberg (Germany)

Presentations

Dapagliflozin exhibits class I antiarrhythmic effects which suppress action potential formation in human atrial cardiomyocytes

Event: ESC Congress 2022

Topic: Cellular Mechanisms of Arrhythmias

Session: Insights into arrhythmia mechanisms

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources